Chemotherapy
332 codes, page 1 of 2.
Chemotherapeutic Agent 200
| Code | Name | Status | Hospitals with prices |
|---|---|---|---|
| HCPCS C9021 | Injection, obinutuzumab, 10 mg | Retired code | |
| HCPCS C9024 | Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine | Retired code | 1 hospital |
| HCPCS C9025 | Injection, ramucirumab, 5 mg | Retired code | |
| HCPCS C9027 | Injection, pembrolizumab, 1 mg | Retired code | |
| HCPCS C9028 | Injection, inotuzumab ozogamicin, 0.1 mg | Retired code | 1 hospital |
| HCPCS C9030 | Injection, copanlisib, 1 mg | Retired code | 5 hospitals |
| HCPCS C9033 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | Retired code | |
| HCPCS C9042 | Injection, bendamustine hcl (belrapzo), 1 mg | Retired code | |
| HCPCS C9045 | Injection, moxetumomab pasudotox-tdfk, 0.01 mg | Retired code | |
| HCPCS C9049 | Injection, tagraxofusp-erzs, 10 mcg | Retired code | |
| HCPCS C9064 | Mitomycin pyelocalyceal instillation, 1 mg | Retired code | 17 hospitals |
| HCPCS C9065 | Injection, romidepsin, non-lyophilized (e.g. liquid), 1mg | Retired code | 17 hospitals |
| HCPCS C9066 | Injection, sacituzumab govitecan-hziy, 2.5 mg | Retired code | 17 hospitals |
| HCPCS C9069 | Injection, belantamab mafodontin-blmf, 0.5 mg | Retired code | 1 hospital |
| HCPCS C9070 | Injection, tafasitamab-cxix, 2 mg | Retired code | 1 hospital |
| HCPCS C9073 | Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose | Retired code | |
| HCPCS C9076 | Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose | Retired code | |
| HCPCS C9080 | Injection, melphalan flufenamide hydrochloride, 1 mg | Retired code | 1 hospital |
| HCPCS C9081 | Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose | Retired code | |
| HCPCS C9082 | Injection, dostarlimab-gxly, 100 mg | Retired code | 1 hospital |
| HCPCS C9083 | Injection, amivantamab-vmjw, 10 mg | Retired code | 1 hospital |
| HCPCS C9084 | Injection, loncastuximab tesirine-lpyl, 0.1 mg | Retired code | 1 hospital |
| HCPCS C9087 | Injection, cyclophosphamide, (auromedics), 10 mg | Retired code | 1 hospital |
| HCPCS C9095 | Inj, tebentafusp-tebn, 1 mcg | Retired code | 1 hospital |
| HCPCS C9142 | Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg | Retired code | 1 hospital |
| HCPCS C9146 | Injection, mirvetuximab soravtansine-gynx, 1 mg | Retired code | 17 hospitals |
| HCPCS C9147 | Injection, tremelimumab-actl, 1 mg | Retired code | 17 hospitals |
| HCPCS C9148 | Injection, teclistamab-cqyv, 0.5 mg | Retired code | 17 hospitals |
| HCPCS C9155 | Injection, epcoritamab-bysp, 0.16 mg | Retired code | 10 hospitals |
| HCPCS C9163 | Injection, talquetamab-tgvs, 0.25 mg | Retired code | 22 hospitals |
| HCPCS C9165 | Injection, elranatamab-bcmm, 1 mg | Retired code | 22 hospitals |
| HCPCS C9169 | Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram | Retired code | 21 hospitals |
| HCPCS C9170 | Injection, tarlatamab-dlle, 1 mg | Retired code | 21 hospitals |
| HCPCS C9174 | Injection, datopotamab deruxtecan-dlnk, 1 mg | Retired code | 9 hospitals |
| HCPCS C9175 | Injection, treosulfan, 50 mg | Retired code | 9 hospitals |
| HCPCS C9257 | Injection, bevacizumab, 0.25 mg | Current code | 29 hospitals |
| HCPCS C9301 | Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose | Retired code | 7 hospitals |
| HCPCS C9302 | Injection, zanidatamab-hrii, 2 mg | Retired code | 11 hospitals |
| HCPCS C9303 | Injection, zolbetuximab-clzb, 1 mg | Retired code | 11 hospitals |
| HCPCS C9306 | Injection, telisotuzumab vedotin-tllv, 1 mg | Retired code | 13 hospitals |
| HCPCS C9442 | Injection, belinostat, 10 mg | Retired code | |
| HCPCS C9449 | Injection, blinatumomab, 1 mcg | Retired code | |
| HCPCS C9453 | Injection, nivolumab, 1 mg | Retired code | |
| HCPCS C9455 | Injection, siltuximab, 10 mg | Retired code | |
| HCPCS C9467 | Injection, rituximab and hyaluronidase, 10 mg | Retired code | 1 hospital |
| HCPCS C9472 | Injection, talimogene laherparepvec, 1 million plaque forming units (pfu) | Retired code | 1 hospital |
| HCPCS C9474 | Injection, irinotecan liposome, 1 mg | Retired code | 1 hospital |
| HCPCS C9475 | Injection, necitumumab, 1 mg | Retired code | 1 hospital |
| HCPCS C9476 | Injection, daratumumab, 10 mg | Retired code | 1 hospital |
| HCPCS C9477 | Injection, elotuzumab, 1 mg | Retired code | 1 hospital |
| HCPCS C9480 | Injection, trabectedin, 0.1 mg | Retired code | 1 hospital |
| HCPCS C9483 | Injection, atezolizumab, 10 mg | Retired code | 1 hospital |
| HCPCS C9485 | Injection, olaratumab, 10 mg | Retired code | 1 hospital |
| HCPCS C9491 | Injection, avelumab, 10 mg | Retired code | 1 hospital |
| HCPCS C9492 | Injection, durvalumab, 10 mg | Retired code | 1 hospital |
| HCPCS C9789 | Instillation of anti-neoplastic pharmacologic/biologic agent into renal pelvis, any method, including all imaging guidance, including volumetric measurement if performed | Current code | 28 hospitals |
| HCPCS J0202 | Injection, alemtuzumab, 1 mg | Current code | 33 hospitals |
| HCPCS J0594 | injection, busulfan, 1 mg | Current code | 36 hospitals |
| HCPCS J0893 | Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg | Current code | 27 hospitals |
| HCPCS J0894 | Injection, decitabine, 1 mg | Current code | 43 hospitals |
| HCPCS J1323 | Injection, elranatamab-bcmm, 1 mg | Current code | 35 hospitals |
| HCPCS J1326 | Injection, zolbetuximab-clzb, 2 mg | Current code | 26 hospitals |
| HCPCS J3055 | Injection, talquetamab-tgvs, 0.25 mg | Current code | 40 hospitals |
| HCPCS J3263 | Injection, toripalimab-tpzi, 1 mg | Current code | 28 hospitals |
| HCPCS J8510 | Busulfan; oral, 2 mg | Current code | 28 hospitals |
| HCPCS J8520 | Capecitabine, oral, 150 mg | Retired code | 2 hospitals |
| HCPCS J8521 | Capecitabine, oral, 500 mg | Retired code | 12 hospitals |
| HCPCS J8522 | Capecitabine, oral, 50 mg | Current code | 24 hospitals |
| HCPCS J8530 | Cyclophosphamide; oral, 25 mg | Current code | 33 hospitals |
| HCPCS J8560 | Etoposide; oral, 50 mg | Current code | 29 hospitals |
| HCPCS J8562 | Fludarabine phosphate, oral, 10 mg | Retired code | 9 hospitals |
| HCPCS J8600 | Melphalan; oral, 2 mg | Current code | 32 hospitals |
| HCPCS J8610 | Methotrexate; oral, 2.5 mg | Current code | 34 hospitals |
| HCPCS J8611 | Methotrexate (jylamvo), oral, 2.5 mg | Current code | 28 hospitals |
| HCPCS J8612 | Methotrexate (xatmep), oral, 2.5 mg | Current code | 28 hospitals |
| HCPCS J8700 | Temozolomide, oral, 5 mg | Current code | 27 hospitals |
| HCPCS J8705 | Topotecan, oral, 0.25 mg | Current code | 28 hospitals |
| HCPCS J8999 | Prescription drug, oral, chemotherapeutic, nos | Current code | 22 hospitals |
| HCPCS J9000 | Injection, doxorubicin hydrochloride, 10 mg | Current code | 39 hospitals |
| HCPCS J9010 | Injection, alemtuzumab, 10 mg | Retired code | 1 hospital |
| HCPCS J9011 | Injection, datopotamab deruxtecan-dlnk, 1 mg | Current code | 20 hospitals |
| HCPCS J9015 | Injection, aldesleukin, per single use vial | Current code | 35 hospitals |
| HCPCS J9017 | Injection, arsenic trioxide, 1 mg | Current code | 43 hospitals |
| HCPCS J9019 | Injection, asparaginase (erwinaze), 1,000 iu | Retired code | 32 hospitals |
| HCPCS J9020 | Injection, asparaginase, not otherwise specified, 10,000 units | Retired code | 23 hospitals |
| HCPCS J9021 | Injection, asparaginase, recombinant, (rylaze), 0.1 mg | Current code | 29 hospitals |
| HCPCS J9022 | Injection, atezolizumab, 10 mg | Current code | 43 hospitals |
| HCPCS J9023 | Injection, avelumab, 10 mg | Current code | 42 hospitals |
| HCPCS J9024 | Injection, atezolizumab, 5 mg and hyaluronidase-tqjs | Current code | 34 hospitals |
| HCPCS J9025 | Injection, azacitidine, 1 mg | Current code | 42 hospitals |
| HCPCS J9026 | Injection, tarlatamab-dlle, 1 mg | Current code | 40 hospitals |
| HCPCS J9027 | Injection, clofarabine, 1 mg | Current code | 37 hospitals |
| HCPCS J9028 | Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram | Current code | 28 hospitals |
| HCPCS J9029 | Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose | Current code | 28 hospitals |
| HCPCS J9030 | Bcg live intravesical instillation, 1 mg | Current code | 31 hospitals |
| HCPCS J9031 | Bcg (intravesical) per instillation | Retired code | 1 hospital |
| HCPCS J9032 | Injection, belinostat, 10 mg | Current code | 28 hospitals |
| HCPCS J9033 | Injection, bendamustine hydrochloride, not otherwise specified, 1 mg | Current code | 41 hospitals |
| HCPCS J9034 | Injection, bendamustine hcl (bendeka), 1 mg | Current code | 44 hospitals |
| HCPCS J9035 | Injection, bevacizumab, 10 mg | Current code | 43 hospitals |
| HCPCS J9036 | Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg | Current code | 34 hospitals |
| HCPCS J9037 | Injection, belantamab mafodotin-blmf, 0.5 mg | Retired code | 24 hospitals |
| HCPCS J9038 | Injection, axatilimab-csfr, 0.1 mg | Current code | 17 hospitals |
| HCPCS J9039 | Injection, blinatumomab, 1 microgram | Current code | 36 hospitals |
| HCPCS J9040 | Injection, bleomycin sulfate, 15 units | Current code | 37 hospitals |
| HCPCS J9041 | Injection, bortezomib, 0.1 mg | Current code | 43 hospitals |
| HCPCS J9042 | Injection, brentuximab vedotin, 1 mg | Current code | 41 hospitals |
| HCPCS J9043 | Injection, cabazitaxel, 1 mg | Current code | 42 hospitals |
| HCPCS J9044 | Injection, bortezomib, not otherwise specified, 0.1 mg | Retired code | 19 hospitals |
| HCPCS J9045 | Injection, carboplatin, 50 mg | Current code | 38 hospitals |
| HCPCS J9046 | Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg | Current code | 33 hospitals |
| HCPCS J9047 | Injection, carfilzomib, 1 mg | Current code | 43 hospitals |
| HCPCS J9048 | Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg | Current code | 40 hospitals |
| HCPCS J9049 | Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg | Current code | 27 hospitals |
| HCPCS J9050 | Injection, carmustine, 100 mg | Current code | 37 hospitals |
| HCPCS J9052 | Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mg | Current code | 27 hospitals |
| HCPCS J9054 | Injection, bortezomib (boruzu), 0.1 mg | Current code | 17 hospitals |
| HCPCS J9055 | Injection, cetuximab, 10 mg | Current code | 43 hospitals |
| HCPCS J9056 | Injection, bendamustine hydrochloride (vivimusta), 1 mg | Current code | 28 hospitals |
| HCPCS J9057 | Injection, copanlisib, 1 mg | Current code | 26 hospitals |
| HCPCS J9058 | Injection, bendamustine hydrochloride (apotex), 1 mg | Retired code | 27 hospitals |
| HCPCS J9059 | Injection, bendamustine hydrochloride (baxter), 1 mg | Retired code | 25 hospitals |
| HCPCS J9060 | Injection, cisplatin, powder or solution, 10 mg | Current code | 38 hospitals |
| HCPCS J9061 | Injection, amivantamab-vmjw, 2 mg | Current code | 36 hospitals |
| HCPCS J9063 | Injection, mirvetuximab soravtansine-gynx, 1 mg | Current code | 42 hospitals |
| HCPCS J9065 | Injection, cladribine, per 1 mg | Current code | 41 hospitals |
| HCPCS J9070 | Cyclophosphamide, 100 mg | Retired code | 25 hospitals |
| HCPCS J9071 | Injection, cyclophosphamide (auromedics), 5 mg | Current code | 30 hospitals |
| HCPCS J9072 | Injection, cyclophosphamide (frindovyx), 5 mg | Current code | 28 hospitals |
| HCPCS J9073 | Injection, cyclophosphamide (dr. reddy's), 5 mg | Current code | 42 hospitals |
| HCPCS J9074 | Injection, cyclophosphamide (sandoz), 5 mg | Current code | 35 hospitals |
| HCPCS J9075 | Injection, cyclophosphamide, not otherwise specified, 5 mg | Current code | 44 hospitals |
| HCPCS J9076 | Injection, cyclophosphamide (baxter), 5 mg | Current code | 33 hospitals |
| HCPCS J9098 | Injection, cytarabine liposome, 10 mg | Retired code | 32 hospitals |
| HCPCS J9100 | Injection, cytarabine, 100 mg | Current code | 33 hospitals |
| HCPCS J9118 | Injection, calaspargase pegol-mknl, 10 units | Current code | 29 hospitals |
| HCPCS J9119 | Injection, cemiplimab-rwlc, 1 mg | Current code | 35 hospitals |
| HCPCS J9120 | Injection, dactinomycin, 0.5 mg | Current code | 42 hospitals |
| HCPCS J9130 | Dacarbazine, 100 mg | Current code | 37 hospitals |
| HCPCS J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | Current code | 42 hospitals |
| HCPCS J9145 | Injection, daratumumab, 10 mg | Current code | 41 hospitals |
| HCPCS J9150 | Injection, daunorubicin, 10 mg | Current code | 41 hospitals |
| HCPCS J9151 | Injection, daunorubicin citrate, liposomal formulation, 10 mg | Retired code | 16 hospitals |
| HCPCS J9153 | Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine | Current code | 36 hospitals |
| HCPCS J9160 | Injection, denileukin diftitox, 300 micrograms | Retired code | 4 hospitals |
| HCPCS J9171 | Injection, docetaxel, 1 mg | Current code | 43 hospitals |
| HCPCS J9172 | Injection, docetaxel (docivyx), 1 mg | Current code | 28 hospitals |
| HCPCS J9173 | Injection, durvalumab, 10 mg | Current code | 42 hospitals |
| HCPCS J9174 | Injection, docetaxel (beizray), 1 mg | Current code | 16 hospitals |
| HCPCS J9176 | Injection, elotuzumab, 1 mg | Current code | 33 hospitals |
| HCPCS J9177 | Injection, enfortumab vedotin-ejfv, 0.25 mg | Current code | 35 hospitals |
| HCPCS J9178 | Injection, epirubicin hcl, 2 mg | Current code | 20 hospitals |
| HCPCS J9179 | Injection, eribulin mesylate, 0.1 mg | Current code | 40 hospitals |
| HCPCS J9181 | Injection, etoposide, 10 mg | Current code | 35 hospitals |
| HCPCS J9185 | Injection, fludarabine phosphate, 50 mg | Current code | 41 hospitals |
| HCPCS J9190 | Injection, fluorouracil, 500 mg | Current code | 37 hospitals |
| HCPCS J9196 | Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg | Current code | 34 hospitals |
| HCPCS J9198 | Injection, gemcitabine hydrochloride, (infugem), 100 mg | Current code | 26 hospitals |
| HCPCS J9199 | Injection, gemcitabine hydrochloride (infugem), 200 mg | Retired code | |
| HCPCS J9200 | Injection, floxuridine, 500 mg | Current code | 35 hospitals |
| HCPCS J9201 | Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | Current code | 40 hospitals |
| HCPCS J9203 | Injection, gemtuzumab ozogamicin, 0.1 mg | Current code | 36 hospitals |
| HCPCS J9204 | Injection, mogamulizumab-kpkc, 1 mg | Current code | 40 hospitals |
| HCPCS J9205 | Injection, irinotecan liposome, 1 mg | Current code | 42 hospitals |
| HCPCS J9206 | Injection, irinotecan, 20 mg | Current code | 36 hospitals |
| HCPCS J9207 | Injection, ixabepilone, 1 mg | Current code | 40 hospitals |
| HCPCS J9208 | Injection, ifosfamide, 1 gram | Current code | 35 hospitals |
| HCPCS J9211 | Injection, idarubicin hydrochloride, 5 mg | Current code | 40 hospitals |
| HCPCS J9212 | Injection, interferon alfacon-1, recombinant, 1 microgram | Retired code | 23 hospitals |
| HCPCS J9213 | Injection, interferon, alfa-2a, recombinant, 3 million units | Current code | 27 hospitals |
| HCPCS J9214 | Injection, interferon, alfa-2b, recombinant, 1 million units | Current code | 34 hospitals |
| HCPCS J9215 | Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu | Current code | 25 hospitals |
| HCPCS J9216 | Injection, interferon, gamma 1-b, 3 million units | Current code | 34 hospitals |
| HCPCS J9223 | Injection, lurbinectedin, 0.1 mg | Current code | 33 hospitals |
| HCPCS J9227 | Injection, isatuximab-irfc, 10 mg | Current code | 30 hospitals |
| HCPCS J9228 | Injection, ipilimumab, 1 mg | Current code | 41 hospitals |
| HCPCS J9229 | Injection, inotuzumab ozogamicin, 0.1 mg | Current code | 36 hospitals |
| HCPCS J9230 | Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg | Current code | 34 hospitals |
| HCPCS J9245 | Injection, melphalan hydrochloride, not otherwise specified, 50 mg | Current code | 34 hospitals |
| HCPCS J9247 | Injection, melphalan flufenamide, 1mg | Retired code | 23 hospitals |
| HCPCS J9248 | Injection, melphalan (hepzato), 1 mg | Current code | 28 hospitals |
| HCPCS J9249 | Injection, melphalan (apotex), 1 mg | Current code | 23 hospitals |
| HCPCS J9250 | Methotrexate sodium, 5 mg | Retired code | 1 hospital |
| HCPCS J9255 | Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg | Current code | 10 hospitals |
| HCPCS J9258 | Injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mg | Retired code | |
| HCPCS J9259 | Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mg | Retired code | 25 hospitals |
| HCPCS J9260 | Injection, methotrexate sodium, 50 mg | Current code | 45 hospitals |
| HCPCS J9261 | Injection, nelarabine, 50 mg | Current code | 36 hospitals |
| HCPCS J9262 | Injection, omacetaxine mepesuccinate, 0.01 mg | Current code | 27 hospitals |
| HCPCS J9263 | Injection, oxaliplatin, 0.5 mg | Current code | 31 hospitals |
| HCPCS J9264 | Injection, paclitaxel protein-bound particles, 1 mg | Current code | 43 hospitals |
| HCPCS J9265 | Injection, paclitaxel, 30 mg | Retired code | 1 hospital |
| HCPCS J9266 | Injection, pegaspargase, per single dose vial | Current code | 40 hospitals |
| HCPCS J9267 | Injection, paclitaxel, 1 mg | Current code | 30 hospitals |
| HCPCS J9268 | Injection, pentostatin, 10 mg | Current code | 35 hospitals |
| HCPCS J9269 | Injection, tagraxofusp-erzs, 10 micrograms | Current code | 28 hospitals |
| HCPCS J9270 | Injection, plicamycin, 2.5 mg | Retired code | 15 hospitals |
| HCPCS J9271 | Injection, pembrolizumab, 1 mg | Current code | 43 hospitals |
| HCPCS J9272 | Injection, dostarlimab-gxly, 10 mg | Current code | 41 hospitals |
| HCPCS J9273 | Injection, tisotumab vedotin-tftv, 1 mg | Current code | 35 hospitals |